Correspondence to editorial on “Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial”

Схожие документы

• Correspondence to editorial on “Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial”
  по: Hyung Joon Yim, и др.
  Опубликовано: (2026-01-01)
• Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
  по: Tae Hyung Kim, и др.
  Опубликовано: (2024-03-01)
• Comparative risk of osteoporosis and fractures in chronic hepatitis B patients: Tenofovir disoproxil fumarate vs. entecavir in a Korean nationwide cohort
  по: Yoon E. Shin, и др.
  Опубликовано: (2025-09-01)
• Comparison of hepatocellular carcinoma incidence after long-term treatment with besifovir vs. tenofovir AF
  по: Hyuk Kim, и др.
  Опубликовано: (2025-02-01)
• Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
  по: Hyeyeon Hong, и др.
  Опубликовано: (2024-01-01)